ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,522Medicare Part D Prescriptions Filled, Including Refills

Rank: 1236 out of 3734

$500K Total Retail Price of All Prescriptions

Rank: 715 out of 3734

261 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 261 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

9% of this provider’s 261 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 5,160 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

37% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$77 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
WARFARIN SODIUM 272 256 1 10
SIMVASTATIN 199 161 2 1
ATORVASTATIN CALCIUM 195 171 3 11
LISINOPRIL 186 144 4 3
POTASSIUM CHLORIDE 136 119 5 19
OMEPRAZOLE 132 94 6 4
NEXIUM 131 98 7 36
FUROSEMIDE 123 98 8 7
AMLODIPINE BESYLATE 123 85 8 5
SYNTHROID 118 102 10 47
METFORMIN HCL 110 93 11 8
DIOVAN 106 86 12 31
LEVOTHYROXINE SODIUM 102 93 13 2
GABAPENTIN 102 72 13 17
PANTOPRAZOLE SODIUM 96 83 15 22
METOPROLOL TARTRATE 91 91 16 6
CYMBALTA 86 44 17 67
SERTRALINE HCL 85 82 18 18
CRESTOR 77 69 19 28
SINGULAIR 76 61 20 95
HYDROCHLOROTHIAZIDE 75 65 21 9
CELEBREX 73 58 22 69
PRAVASTATIN SODIUM 72 64 23 15
METOPROLOL SUCCINATE 72 55 23 14
QUINAPRIL HCL 72 48 23 74
HYDROCODONE-ACETAMINOPHEN 72 46 S3 23 12
CITALOPRAM HBR 70 50 27 16
SPIRIVA 67 53 28 40
RANITIDINE HCL 63 58 29 32
ALENDRONATE SODIUM 61 58 30 26
ZETIA 60 55 31 55
VENLAFAXINE HCL ER 60 53 31 84
LOSARTAN POTASSIUM 57 54 33 21
MIRTAZAPINE 56 56 34 45
GLIMEPIRIDE 53 53 35 37
MONTELUKAST SODIUM 53 40 35 175
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 20, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.